The Central Drug Standard Control Organization vide F. No. Enforc-11021(11)/34/2026-eoffice-Part(1), issued Advisory on Strengthening Enforcement against Unauthorized Promotion and Distribution of GLP-1 Based Drugs. Please refer the advisory for more details.